BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boix-Montesinos P, Soriano-Teruel PM, Armiñán A, Orzáez M, Vicent MJ. The past, present, and future of breast cancer models for nanomedicine development. Adv Drug Deliv Rev 2021;173:306-30. [PMID: 33798642 DOI: 10.1016/j.addr.2021.03.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Rijcken CJ, De Lorenzi F, Biancacci I, G.j.m. Hanssen R, Thewissen M, Hu Q, Atrafi F, Liskamp RM, Mathijssen RH, Miedema IH, Willemien Menke - van der Houven van Oordt C, A.m.s. van Dongen G, Vugts DJ, Timmers M, Hennink WE, Lammers T. Design, Development and Clinical Translation of CriPec®-based Core-Crosslinked Polymeric Micelles. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114613] [Reference Citation Analysis]
2 Cascallar M, Hurtado P, Lores S, Pensado-lópez A, Quelle-regaldie A, Sánchez L, Piñeiro R, de la Fuente M. Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1007018] [Reference Citation Analysis]
3 Li W, Gong H, Fu Y, Sun J, Wang Y. Novel pH-sensitive nanoparticles based on prodrug strategy to delivery All-Trans Retinoic Acid for breast cancer. Colloids Surf B Biointerfaces 2022;219:112838. [PMID: 36148708 DOI: 10.1016/j.colsurfb.2022.112838] [Reference Citation Analysis]
4 Xue W, Sun C, Yuan H, Yang X, Zhang Q, Liao Y, Guo H, Zhuo Z. Establishment and Analysis of an Individualized EMT-Related Gene Signature for the Prognosis of Breast Cancer in Female Patients. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/1289445] [Reference Citation Analysis]
5 Zuo R, Zhang Y, Chen X, Hu S, Song X, Gao X, Gong J, Ji H, Yang F, Peng L, Fang K, Lv Y, Zhang J, Jiang S, Guo D. Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis. Int J Nanomedicine 2022;17:2475-91. [PMID: 35668999 DOI: 10.2147/IJN.S352538] [Reference Citation Analysis]
6 Masuda N, Ono M, Mukohara T, Yasojima H, Shimoi T, Kobayashi K, Harano K, Mizutani M, Tanioka M, Takahashi S, Kogawa T, Suzuki T, Okumura S, Takase T, Nagai R, Semba T, Zhao Z, Ren M, Yonemori K. Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort. European Journal of Cancer 2022;168:108-18. [DOI: 10.1016/j.ejca.2022.03.004] [Reference Citation Analysis]
7 Satchi-Fainaro R, Florindo HF, Vicent MJ. Clinically-relevant and predictive cancer models for nanomedicine evaluation. Adv Drug Deliv Rev 2022;183:114140. [PMID: 35134434 DOI: 10.1016/j.addr.2022.114140] [Reference Citation Analysis]
8 Fan W, Wei Q, Xiang J, Tang Y, Zhou Q, Geng Y, Liu Y, Sun R, Xu L, Wang G, Piao Y, Shao S, Zhou Z, Tang J, Xie T, Li Z, Shen Y. Mucus Penetrating and Cell-Binding Polyzwitterionic Micelles as Potent Oral Nanomedicine for Cancer Drug Delivery. Adv Mater 2022;34:e2109189. [PMID: 35196415 DOI: 10.1002/adma.202109189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li J, Zhang P, Zhou M, Liu C, Huang Y, Li L. Trauma-Responsive Scaffold Synchronizing Oncolysis Immunization and Inflammation Alleviation for Post-Operative Suppression of Cancer Metastasis. ACS Nano 2022. [PMID: 35344338 DOI: 10.1021/acsnano.1c11562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Banthia P, Gambhir L, Sharma A, Daga D, Kapoor N, Chaudhary R, Sharma G. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech 2022;12:70. [PMID: 35223356 DOI: 10.1007/s13205-022-03121-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yang L, Jia J, Li S. Advances in the Application of Exosomes Identification Using Surface-Enhanced Raman Spectroscopy for the Early Detection of Cancers. Front Bioeng Biotechnol 2022;9:808933. [DOI: 10.3389/fbioe.2021.808933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Alshayeji MH, Ellethy H, Abed S, Gupta R. Computer-aided detection of breast cancer on the Wisconsin dataset: An artificial neural networks approach. Biomedical Signal Processing and Control 2022;71:103141. [DOI: 10.1016/j.bspc.2021.103141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Imparato G, Urciuolo F, Mazio C, Netti PA. Capturing the spatial and temporal dynamics of tumor stroma for on-chip optimization of microenvironmental targeting nanomedicine. Lab Chip 2022. [DOI: 10.1039/d2lc00611a] [Reference Citation Analysis]
14 Bağcı G, Ximenes-carballo C, Perez-amodio S, Castaño O, Engel E, Blanco-fernandez B. Advanced 3D In Vitro Models to Recapitulate the Breast Tumor Microenvironment. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_56] [Reference Citation Analysis]
15 Gris-cárdenas I, Rábano M, Vivanco MDM. Patient-Derived Explant Cultures of Normal and Tumor Human Breast Tissue. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2193-6_17] [Reference Citation Analysis]
16 Park H, Otte A, Park K. Evolution of drug delivery systems: From 1950 to 2020 and beyond. J Control Release 2021;342:53-65. [PMID: 34971694 DOI: 10.1016/j.jconrel.2021.12.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 22.0] [Reference Citation Analysis]
17 Tuli HS, Sak K, Adhikary S, Kaur G, Aggarwal D, Kaur J, Kumar M, Parashar NC, Parashar G, Sharma U, Jain A. Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets. Exp Biol Med (Maywood) 2021;:15353702211062510. [PMID: 34904901 DOI: 10.1177/15353702211062510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zhou W, Lin Z, Xiong Y, Xue H, Song W, Yu T, Chen L, Hu Y, Panayi AC, Sun Y, Cao F, Liu G, Hu L, Yan C, Xie X, Qiu W, Mi B, Liu G. Dual-Targeted Nanoplatform Regulating the Bone Immune Microenvironment Enhances Fracture Healing. ACS Appl Mater Interfaces 2021;13:56944-60. [PMID: 34797653 DOI: 10.1021/acsami.1c17420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 George TA, Chen MM, Czosseck A, Chen HP, Huang HS, Lundy DJ. Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer. J Control Release 2021;342:31-43. [PMID: 34896187 DOI: 10.1016/j.jconrel.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Takemoto H, Nishiyama N. Construction of nanomaterials based on pH-responsive polymers for effective tumor delivery. Polym J 2021;53:1353-1360. [DOI: 10.1038/s41428-021-00542-7] [Reference Citation Analysis]
21 Ebrahimnejad P, Sodagar Taleghani A, Asare-Addo K, Nokhodchi A. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer. Drug Discov Today 2021:S1359-6446(21)00490-6. [PMID: 34781032 DOI: 10.1016/j.drudis.2021.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
22 Lv J, Xie M, Zhao S, Qiu W, Wang S, Cao M. Synergetic fabrication of hybrid drug formulation using biodegradable tri-block copolymeric liquid nanoparticle delivery for gastric cancer chemotherapy. Journal of Molecular Liquids 2021;340:117066. [DOI: 10.1016/j.molliq.2021.117066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Dai R, Peng X, Lin B, Xu D, Lv R. NIR II Luminescence Imaging for Sentinel Lymph Node and Enhanced Chemo-/Photothermal Therapy for Breast Cancer. Bioconjug Chem 2021;32:2117-27. [PMID: 34470215 DOI: 10.1021/acs.bioconjchem.1c00393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Xiong J, Yuan H, Wu H, Cheng J, Yang S, Hu T. Black phosphorus conjugation of chemotherapeutic ginsenoside Rg3: enhancing targeted multimodal nanotheranostics against lung cancer metastasis. Drug Deliv 2021;28:1748-58. [PMID: 34463184 DOI: 10.1080/10717544.2021.1966129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res 2021. [PMID: 34302274 DOI: 10.1007/s13346-021-01024-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]